- abnormal abdominal fat pad morphology / MGI
- abnormal Purkinje cell morphology / MGI
- increased body weight / MGI
- decreased body weight / MGI
- hyperactivity / MGI
- impaired coordination / MGI
- abnormal lipid level / MGI
- reduced fertility / MGI
- decreased litter size / MGI
- increased circulating insulin level / MGI
- hepatic steatosis / MGI
- enlarged seminal vesicle / MGI
- increased insulin secretion / MGI
- nervous system phenotype / MGI
- increased pancreatic beta cell number / MGI
- increased circulating cholesterol level / MGI
- behavior/neurological phenotype / MGI
- intrahepatic cholestasis / MGI
- increased susceptibility to weight gain / MGI
- pancreatic islet hyperplasia / MGI
- decreased circulating glucose level / MGI
- increased gonadal fat pad weight / MGI
- increased liver glycogen level / MGI
- prenatal lethality, incomplete penetrance / MGI
B6.129S2-Atxn2tm2.1Aub/Ph
Status | Available to order |
EMMA ID | EM:10693 |
Citation information | RRID:IMSR_EM:10693 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | B6.129S2-Atxn2tm2.1Aub/Ph |
Alternative name | Atxn2-CAG42-knockin |
Strain type | Targeted Mutant Strains : Knock-in |
Allele/Transgene symbol | Atxn2tm2.1Aub |
Gene/Transgene symbol | Atxn2 |
Information from provider
Provider | Georg Auburger |
Provider affiliation | Experimental Neurology, Goethe University Medical School |
Genetic information | As a model of the human neurodegenerative disease Spinocerebellar Ataxia type 2 (SCA2), a typical mutant triplet repeat size of (CAG)42 replaced the wild-type (CAG)1 at the corresponding site in the murine Atxn2 gene, as a knock-in by homologous recombination. |
Phenotypic information | Homozygous:Slight cerebellar ataxia from the age of 12-24 months, depending on the inbred background (manifesting earlier in the C57BL/6 background).Heterozygous:Subtle cerebellar ataxia detectable in groups of mutant mice by objective accelerating rotarod tests by age 21 months. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Animals used for archiving | heterozygous males |
Disease and phenotype information
MGI allele-associated human disease models
Orphanet associated rare diseases, based on orthologous gene matching
- Spinocerebellar ataxia type 2 / Orphanet_98756
MGI phenotypes (gene matching)
Literature references
- ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice.;Damrath Ewa, Heck Melanie V, Gispert Suzana, Azizov Mekhman, Nowock Joachim, Seifried Carola, Rüb Udo, Walter Michael, Auburger Georg, ;2012;PLoS genetics;8;e1002920; 22956915
- Both ubiquitin ligases FBXW8 and PARK2 are sequestrated into insolubility by ATXN2 PolyQ expansions, but only FBXW8 expression is dysregulated.;Halbach Melanie Vanessa, Stehning Tanja, Damrath Ewa, Jendrach Marina, Şen Nesli Ece, Başak A Nazlı, Auburger Georg, ;2015;PloS one;10;e0121089; 25790475
- Atxn2 Knockout and CAG42-Knock-in Cerebellum Shows Similarly Dysregulated Expression in Calcium Homeostasis Pathway.;Halbach Melanie Vanessa, Gispert Suzana, Stehning Tanja, Damrath Ewa, Walter Michael, Auburger Georg, ;2017;Cerebellum (London, England);16;68-81; 26868665
- Ataxin-2 polyglutamine expansions aberrantly sequester TDP-43 ribonucleoprotein condensates disrupting mRNA transport and local translation in neurons.;Wijegunawardana Denethi, Nayak Asima, Vishal Sonali S, Venkatesh Neha, Gopal Pallavi P, ;2025;Developmental cell;60;253-269.e5; 39419034
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).